Cost Efficacy and Challenges of Real-world Brolucizumab use for Neovascular AMD

被引：0
|
作者：
Sharma, Kayshaliya [1 ,2 ]
Rave, Vanessa [1 ,2 ]
Wagner, Alan [1 ]
Kapoor, Kapil [1 ]
机构：
[1] Wagner Kapoor Res Inst, Norfolk, VA USA
[2] Eastern Virginia Med Sch, Norfolk, VA 23501 USA
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2021年 / 62卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
432
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Real-world experience with brolucizumab in neovascular age-related macular degeneration over 2 years: the REBA extension study
    Bilgic, Alper
    Kodjikian, Laurent
    de Ribot, Francesc March
    Spitzer, Martin S.
    Vasavada, Vaishali
    Gonzalez-Cortes, Jesus Hernan
    Sudhalkar, Aditya
    Chakraborty, Somnath
    Mathis, Thibaud
    [J]. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2024, 262 (04) : 1161 - 1167
  • [32] Real-World Experience Using Intravitreal Brolucizumab Alone or in Combination with Aflibercept in the Management of Neovascular Age-Related Macular Degeneration
    Mehta, Neesurg
    Fong, Rodney
    Wilson, Machelle
    Moussa, Kareem
    Emami-Naeini, Parisa
    Moshiri, Ala
    Yiu, Glenn
    Park, Susanna S.
    [J]. CLINICAL OPHTHALMOLOGY, 2023, 17 : 657 - 665
  • [33] Efficacy and safety of brolucizumab in age-related macular degeneration: A systematic review of real-world studies
    Baumal, Caroline R.
    Sorensen, Torben Lykke
    Karcher, Helene
    Freitas, Rita L.
    Becher, Anja
    Balez, Sebastien
    Clemens, Andreas
    Singer, Michael
    Kodjikian, Laurent
    [J]. ACTA OPHTHALMOLOGICA, 2023, 101 (02) : 123 - 139
  • [34] Therapie der AMD: Real-World-Daten zur Sicherheit von Brolucizumab
    不详
    [J]. KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 2022, 239 (11) : 1294 - 1295
  • [35] Review on the Safety and Efficacy of Brolucizumab for Neovascular Age-Related Macular Degeneration Erratum Major Studies and Real-World Data (vol 12, pg 168, 2023)
    Chen, Dinah
    Ran, An Ran
    Tan, Ting Fang
    Ramachandran, Rithambara
    Li, Fei
    Cheung, Carol Y.
    Yousefi, Siamak
    Tham, Clement C. Y.
    Ting, Daniel S. W.
    Zhang, Xiulan
    Al-Aswad, Lama A.
    [J]. ASIA-PACIFIC JOURNAL OF OPHTHALMOLOGY, 2023, 12 (04): : 422 - 422
  • [36] Real World Vienna: The VIBES Study - Outcomes and procedures in neovascular AMD
    Gerendas, Bianca S.
    Sadeghipour, Amir
    Buehl, Wolf
    Sacu, Stefan
    Schmidt-Erfurth, Ursula
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
  • [37] Intravitreal aflibercept for neovascular AMD in the very elderly neovascular AMD patients: UK Multi-centre Real World Outcome
    Talks, James
    Sivaprasad, Sobha
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
  • [38] Real-World Computer Vision for Real-World Applications: Challenges and Directions
    Tabkhi, Hamed
    [J]. INTELLIGENT SYSTEMS AND APPLICATIONS, VOL 1, 2023, 542 : 727 - 750
  • [39] Real-World Experience With Brolucizumab 6 mg for Diabetic Macular Edema
    Braganca, Francisca
    Ferreira, Andre
    Leite, Joao
    Coelho, Joao
    Borges, Tania
    Caiado, Filipa
    Correia, Nuno
    Beirao, Joao
    Meneres, Pedro
    Pessoa, Bernardete
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (01)
  • [40] RETINAL VASCULITIS OR VASCULAR OCCLUSION AFTER BROLUCIZUMAB FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION A Systematic Review of Real-World Evidence
    Wykoff, Charles C.
    Matsumoto, Hidetaka
    Barakat, Mark R.
    Karcher, Helene
    Lozama, Anthony
    Mayhook, Andrew
    Oshagbemi, Olorunfemi A.
    Zorina, Olessia
    Hassan, Tarek S.
    Khanani, Arshad M.
    Heier, Jeffrey S.
    [J]. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2023, 43 (07): : 1051 - 1063
12345